- Home
- SPXX vs CYRX Comparison
SPXX vs CYRX Comparison
Compare SPXX & CYRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SPXX
- CYRX
- Stock Information
- Founded
- SPXX 2004
- CYRX 1999
- Country
- SPXX United States
- CYRX United States
- Employees
- SPXX N/A
- CYRX N/A
- Industry
- SPXX Trusts Except Educational Religious and Charitable
- CYRX Biotechnology: Pharmaceutical Preparations
- Sector
- SPXX Finance
- CYRX Health Care
- Exchange
- SPXX Nasdaq
- CYRX Nasdaq
- Market Cap
- SPXX 329.9M
- CYRX 310.4M
- IPO Year
- SPXX N/A
- CYRX N/A
- Fundamental
- Price
- SPXX $16.84
- CYRX $6.37
- Analyst Decision
- SPXX
- CYRX Strong Buy
- Analyst Count
- SPXX 0
- CYRX 6
- Target Price
- SPXX N/A
- CYRX $11.33
- AVG Volume (30 Days)
- SPXX 51.3K
- CYRX 649.7K
- Earning Date
- SPXX 01-01-0001
- CYRX 03-04-2025
- Dividend Yield
- SPXX 7.55%
- CYRX N/A
- EPS Growth
- SPXX N/A
- CYRX N/A
- EPS
- SPXX N/A
- CYRX N/A
- Revenue
- SPXX N/A
- CYRX $228,385,000.00
- Revenue This Year
- SPXX N/A
- CYRX $9.18
- Revenue Next Year
- SPXX N/A
- CYRX $8.65
- P/E Ratio
- SPXX N/A
- CYRX N/A
- Revenue Growth
- SPXX N/A
- CYRX N/A
- 52 Week Low
- SPXX $13.57
- CYRX $4.58
- 52 Week High
- SPXX $16.05
- CYRX $20.11
- Technical
- Relative Strength Index (RSI)
- SPXX 34.20
- CYRX 54.54
- Support Level
- SPXX $17.00
- CYRX $5.90
- Resistance Level
- SPXX $17.47
- CYRX $6.60
- Average True Range (ATR)
- SPXX 0.26
- CYRX 0.61
- MACD
- SPXX 0.00
- CYRX 0.09
- Stochastic Oscillator
- SPXX 28.87
- CYRX 81.47
About SPXX Nuveen S&P 500 Dynamic Overwrite Fund
Nuveen S&P 500 Dynamic Overwrite Fund is a diversified closed-end management investment company. Its investment objective is to seek attractive total returns with less volatility than the S&P 500 Index by investing in a U.S. equity portfolio that seeks to substantially replicate the price movements of the S&P 500 Index, as well as selling call options on 35%-75% of the notional value of the Fund's equity portfolio (with a 55% long-term target) in an effort to enhance the Fund's risk-adjusted returns.
About CYRX CryoPort Inc.
CryoPort Inc is a leader serving the life sciences industry as a provider of integrated temperature-controlled supply chain solutions supporting the life sciences in the biopharma/pharma, animal health, and reproductive medicine markets. It operates in two reportable segments: Life Sciences Services and Life Sciences Products. Geographically the company operates in the Americas, Europe, the Middle East and Africa (EMEA), and Asia Pacific (APAC), generating a majority of its revenue from the Americas.